retatrutide mechanism triple agonist gip glp-1 glucagon receptor Retatrutide: How the Compares to Tirzepatide retatrutide mechanism triple agonist glp-1
Description
Several studies systematically investigating the potential association of GLP-1RAs with bowel obstruction utilized large medical databases
Engl., vol
Ahadiat S-A, Hosseinian Z
A multidisciplinary panel of endocrinologists recently advised clinicians to extend the dose-escalation phase or pause dose increases if patients are experiencing GI adverse effects (source)
Available from: www.accessdata.fda.gov/drugsatfda_docs/label/2017/209637lbl.pdf [Last accessed: December 31, 2023]
Auto-injectors, for example, offer an administration route that some patients may prefer over traditional syringe injections
